OTCMKTS:MDCLMedicine Man Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medicine Man Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.25 +0.18 (+16.82 %) (As of 08/13/2020 04:00 PM ET) Add Compare Share Today's Range$1.06Now: $1.25▼$1.2750-Day Range$1.07MA: $1.46▼$1.7952-Week Range$1.05Now: $1.25▼$4.05Volume121,599 shsAverage Volume84,948 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestSocial Media Medicine Man Technologies, Inc. provides cultivation consulting services for cannabis growing technologies and methodologies. The company also provides licensing and seminar services. In addition, it engages in retail operations of cannabis products. The company was founded in 2014 and is based in Denver, Colorado.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Medicine Man Technologies. Previous Next 2.7 Community Rank Outperform VotesMedicine Man Technologies has received 104 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedicine Man Technologies has received 90 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedicine Man Technologies has received 53.61% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medicine Man Technologies and other stocks. Vote “Outperform” if you believe MDCL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDCL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedicine Man Technologies does not currently pay a dividend.Dividend GrowthMedicine Man Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medicine Man Technologies insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Business Services Sub-IndustryCannabis SectorIndustrials Current SymbolOTCMKTS:MDCL Previous SymbolNASDAQ:MDCL CUSIPN/A CIK1622879 Webmedicinemantechnologies.com Phone+1-303-3710387Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees25 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $1.25 +0.18 (+16.82 %) (As of 08/13/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive MDCL News and Ratings via Email Sign-up to receive the latest news and ratings for MDCL and its competitors with MarketBeat's FREE daily newsletter. Medicine Man Technologies (OTCMKTS:MDCL) Frequently Asked Questions How has Medicine Man Technologies' stock price been impacted by Coronavirus (COVID-19)? Medicine Man Technologies' stock was trading at $1.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MDCL shares have decreased by 23.8% and is now trading at $1.25. View which stocks have been most impacted by COVID-19. Has Medicine Man Technologies been receiving favorable news coverage? Media coverage about MDCL stock has been trending positive this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Medicine Man Technologies earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news about Medicine Man Technologies. Are investors shorting Medicine Man Technologies? Medicine Man Technologies saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 232,900 shares, a decline of 31.6% from the March 15th total of 340,600 shares. Based on an average daily volume of 179,900 shares, the days-to-cover ratio is currently 1.3 days. View Medicine Man Technologies' Short Interest. Who are some of Medicine Man Technologies' key competitors? Some companies that are related to Medicine Man Technologies include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), OrganiGram (OGI), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), 22nd Century Group (XXII), KushCo (KSHB), General Cannabis (CANN), Grow Capital (GRWC), Terra Tech (TRTC), mCig (MCIG) and Nemus Bioscience (NMUS). View all competitors. What other stocks do shareholders of Medicine Man Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Canopy Growth (CGC), Curaleaf (CURLF), Aurora Cannabis (ACB), Trulieve Cannabis (TCNNF), Charlotte's Web (CWBHF), Green Thumb Industries (GTBIF), Innovative Industrial Properties (IIPR), KushCo (KSHB), OrganiGram (OGI) and NVIDIA (NVDA). Who are Medicine Man Technologies' key executives? Medicine Man Technologies' management team includes the following people: Mr. Paul D. Dickman, Chairman, Corp. Sec. & Interim CFO (Age 39)Mr. Andrew Williams, Co-Founder, Director & CEO (Age 50)Mr. Joshua Haupt, Chief Revenue Officer (Age 32)Mr. Joseph P. Puglise, COO & Director (Age 49)Mr. James S. Toreson, Consultant (Age 77) What is Medicine Man Technologies' stock symbol? Medicine Man Technologies trades on the OTCMKTS under the ticker symbol "MDCL." How do I buy shares of Medicine Man Technologies? Shares of MDCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Medicine Man Technologies' stock price today? One share of MDCL stock can currently be purchased for approximately $1.25. What is Medicine Man Technologies' official website? The official website for Medicine Man Technologies is medicinemantechnologies.com. How can I contact Medicine Man Technologies? Medicine Man Technologies' mailing address is 4880 Havana St, DENVER, CO 80239-2402, United States. The company can be reached via phone at +1-303-3710387. This page was last updated on 8/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
